# Phase 11G Closure Audit — 2026-09-16 19:00Z

Status: **ACTIVE / NOT READY FOR CLOSURE**

## Accepted evidence state

Latest accepted prospective cutoff:

`2026-09-16T19:00:00Z`

State:

- frozen strategy `candidate_rule_set_v2_2`
- eligible observations `61`
- unique primary families `47`
- resolved primary families `47`
- unresolved primary families `0`
- wins/losses `13/34`
- expectancy `-0.5989123384630131R`
- confirmation families `3`
- confirmation resolved `3`
- current open families `0`
- holdout false
- production action false

## Infrastructure/evidence governance

Current gates:

- canonical provider capture operational
- pipeline v2 operational
- resolver v1.3 fail-closed continuity guard operational
- ledger v1.2 accepted with immutable first-seen event payloads
- prereg boundary preserved at `2026-09-16T13:00:00Z`
- confirmation/discovery cohorts remain separated
- evidence tracker PASS
- portfolio-risk diagnostics PASS
- current-state source-hash verification `5/5 PASS`
- production remains read-only

The `19:00Z` resolver failure exposed ledger v1.1 latest-payload overwrite. Resolver v1.3 correctly refused the drifted prior identity. Ledger v1.2 fixes causal event immutability without modifying strategy rules, resolver tolerances or accepted sample membership.

Acceptance record:

`docs/research/PROSPECTIVE_LEDGER_V1_2_ACCEPTANCE_2026-09-16.md`

## Path A — evidence threshold

Closure criterion remains at least `100` resolved prospective primary families.

Current:

- resolved `47/100`
- shortfall `53`

Therefore Path A is **NOT READY**.

The preregistered confirmation sample is fully resolved (`3/3`) but is far too small to authorize frozen-strategy changes or closure conclusions.

## Path B — explicit user termination

Not selected.

## Holdout

Holdout remains `UNTOUCHED / NOT AUTHORIZED`.

No holdout evidence has been opened or consumed.

## Economic / diagnostic interpretation

Current prospective expectancy remains negative at `-0.5989123384630131R` across `47` resolved primary families.

This remains diagnostic evidence. It does not by itself authorize:

- in-place retuning of frozen v2.2
- changing RR or max hold
- changing side filters or risk gates
- opening the holdout
- enabling production execution
- activating Phase 12

Broad strategy-discovery/self-improving-strategy research remains delegated to `K_Investigation_Forecast` and is outside this Phase 11G continuation.

## Closure verdict

Phase 11G remains **ACTIVE**.

Next permitted evidence action is continued causal collection at fully closed M15 cutoffs using pipeline v2, resolver v1.3 and ledger v1.2, with prior accepted outcomes from `20260916T190000Z`.